Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 1, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
In the latest iteration of our Gold Standard Centers, through dedicated research into biomarker discovery and patient care, the neuroimmunology laboratory at Mayo Clinic has paved a new way of life for those with autoimmune disorders.
The NeurologyLive® team assembled some of the best discussions with leaders in headache and migraine medicine following the 2022 American Headache Society (AHS) Annual Scientific Meeting.
The associate professor in the Department of Rehabilitation Medicine at NYU Langone discussed a recent study on a new tool aimed at quantifying movements during stroke rehabilitation and provided insight on advantages it might bring to the field, the overall quantitative approach, and the main take-home points from the study.
In this European Academy of Neurology Annual Congress-themed NeurologyLive® News Network, John DeLuca, PhD, provides an overview of changes in cognition and brain volume loss in patients with multiple sclerosis.
As the individualized needs of patients are further prioritized in Parkinson disease care, the director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute shared her perspective on shared decision-making.